Our Experts
Work with Industry Thought Leaders at Every Stage of Your Clinical Research Study
With so much at stake, you want the best minds focused on your clinical trial. ERG delivers, with teams of experts working on every facet.
Andria Chastain
President, Evolution Research Group
- Responsible for all clinical operations across the ERG portfolio, working closely with the medical and operational teams and bridging communication with the corporate leaders in finance, business development, and human capital
- Industry veteran who oversaw clinical operations at several large multi-site SMOs
- Has worked on more than 100 early- to late-phase clinical trials
- Provided clinical operations and project management services to Thievon-Wright and has been with ERG since its inception
- Holds a degree from the University of North Carolina (BA, Psychology)
Clayton Dehn, MS
Chief Scientific Officer
- Published in numerous peer-reviewed journal articles
- Conducted 160+ Phase I-IV clinical trials with challenging population inclusive of Diabetes, Vulvovaginal Candidiasis, Healthy Volunteers, Hypogonadal, Liver Disease, Coronary Artery Disease, NASH, Postpartum Depression, Alzheimer’s, and many other medical as well as psychiatric indications
- Commissioner of the Arizona Biomedical Research Commission, Editor-In-Chief of Series of Endocrinology Diabetes and Metabolism and Editorial Board Member of various well-established journals
Ana Fuquay, MS, CCRC
Executive Director, Clinical Operations
- Has participated in numerous late-phase clinical trials in CNS, with a focus on Alzheimer’s disease
- Manages clinical and business operations at clinical trial sites in Delray Beach, FL and Stuart, FL
- Holds degrees from Nova Southeastern University (MS, Mental Health Counseling) and Florida Atlantic University (BA)
Staci Maroney, MPH
Director of Regulatory Affairs, Evolution Research Group
- Responsible for company-wide implementation and development of eRegulatory system, eRegulatory Work Instructions and onboard sites to eRegulatory system
- Oversee maintenance of study documents in accord with FDA and other regulatory agency/guidance requirements
- Holds Degrees from Johns Hopkins University School of Hygiene and Public Health (M.P.H.) and Trinity University (BA)
- Published by the Academic Emergency Medicine journal
Ashley Poole, CCRC
Regional Director of Clinical Operations, Evolution Research Group
- Industry leader in clinical trial site operations and day-to-day site management
- Participated in more that 150 clinical trials in various therapeutic areas including psychiatry, pediatrics and pain
- Frequently engaged to serve on advisory boards by sponsors working on programs addressing chronic mental illness
- Holds a degree from the University of South Florida (BS)
Janeen Rosales
Vice President, Therapeutic Portfolio Lead
- Executive Director of Operations
- Has helped execute more than 250 clinical trials
- Previously worked as the Chief Executive Officer for Research Centers of America
- Experience overseeing divisions including Early and Late Phase Clinical Trial Implementation and Execution, Business Development, Quality Assurance/Control, Regulatory, Data Management, Marketing, Recruitment, Pharmacy and Laboratory Services
- Certified Clinical Research Coordinator
- Received her Master’s degree in Clinical Research Organization and Management from Drexel University School of Medicine; BS in Biology from Denison University
Cooper Shamblen
Vice President of Operations, Clinical Pharmacology of Miami
- Involved in all aspects of study conduct for more than 1800 clinical trials with a focus on Phase I studies
- Cofounder of Clinical Pharmacology Associates and Clinical Pharmacology of Miami
Adam Smith, PhD
Investigator, Site Director, Richmond Behavioral Associates
- Investigator and Site Director at Richmond Behavioral Associates with 30+ years of experience
- Has held various clinical positions such as program director, senior psychologist, and director
- Holds Degrees from Nova Southeastern University (Ph.D), and Baruch College (MBA)
- Has conducted 80+ clinical trials with challenging populations inclusive of Schizophrenia, ADHD, Bipolar Disorder, Anxiety, Major Depressive Disorder, Alzheimer’s Disease, Post Traumatic Stress Disorder, Obsessive Compulsive Disorder, treatment resistant disorders, and many other psychiatric and neurological indications
Matty Lynch
Executive Vice President, Strategic Operations